Pre-Submission Meetings Explained: Ultimate Guide to Regulatory Strategy and Compliance Mastering Pre-Submission Meetings: Compliance-Ready Guide for FDA, EMA, and Global Agencies Introduction to Pre-Submission Meetings and Their Importance Pre-submission meetings are structured consultations between sponsors and regulatory agencies to discuss key development plans, dossier expectations, and submission strategies before filing major applications such as INDs, NDAs, BLAs, ANDAs, or CTAs. These meetings provide a forum for aligning sponsor strategies with regulatory expectations, reducing risk of deficiencies or rejections. In the U.S., the FDA categorizes pre-submission meetings as Type A, Type B, or Type C, depending on the purpose and urgency….

PMDA Approval Process Demystified: Insider Guide to Japanese Regulatory Affairs Your Insider Roadmap to Navigating PMDA Regulatory Affairs in Japan Introduction to PMDA Regulatory Affairs and Its Importance The Pharmaceuticals and Medical Devices Agency (PMDA) is Japan’s regulatory authority responsible for evaluating the quality, safety, and efficacy of pharmaceuticals, medical devices, and regenerative medicine products. Working closely with the Ministry of Health, Labour and Welfare (MHLW), PMDA ensures that only safe and effective therapies reach the Japanese population. With Japan being the third-largest pharmaceutical market in the world, obtaining PMDA approval is a strategic priority for global pharma and biotech…